Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReckitt Regulatory News (RKT)

Share Price Information for Reckitt (RKT)

Share Price is delayed by 15 minutes
Get Live Data
4,648.00    108.00 (2.38%)
Bid:
4,623.00
Ask:
4,625.00
Spread: 2.00 (0.043%)
Market Cap: £29.56b
RKT Live PriceLast checked at - London Stock Exchange

Intraday Reckitt Share Chart

Directorate Change

13 Dec 2022 10:30

RNS Number : 5264J
Reckitt Benckiser Group PLC
13 December 2022
 

13 December 2022

 

RECKITT BENCKISER GROUP PLC

DIRECTORATE CHANGE

 

Reckitt announces the appointment of

Tamara Ingram OBE as Non-Executive Director

 

 

Reckitt Benckiser Group plc today announces the appointment of Tamara Ingram OBE to the Board as a Non-Executive Director and member of the Audit Committee, effective 1 February 2023.

 

Tamara Ingram has had an extensive career in advertising, marketing and digital communication and has a deep understanding of consumer brands and digital strategy. Tamara was the Global Chair of Wunderman Thompson until the end of 2020 and prior to that held various leadership roles at WPP plc, including Global Chief Executive Officer of J. Walter Thompson, and at WPP's wholly owned data investment division, Kantar. Prior to joining WPP plc, Tamara was Chief Executive Officer of McCann Worldgroup in London and Chief Executive Officer of Saatchi & Saatchi's London office.

 

Tamara is currently a non-executive director of Marks and Spencer Group plc and Chair of their ESG Committee. She is also a non-executive director at Intertek Group plc and a member of their Remuneration Committee, as well as a non-executive director of Marsh & McLennan Companies, Inc. and a member of their Audit and ESG Committees. Tamara was previously a non-executive director of the Sage Group plc and Serco Group plc. Tamara is also Chair of the Trustees of Asthma + Lung UK.

 

Commenting on the appointment, Chris Sinclair, Chair of the Board said:

 

"I am delighted that Tamara has agreed to join the Reckitt Board. She is an outstanding leader, with considerable expertise in global marketing services and has led renowned marketing campaigns for household brands around the world. We welcome the value she will bring to the Board."

 

The Company confirms that there is no further information to be disclosed under the requirements of Listing Rule 9.6.13R in relation to Tamara's appointment.

 

 

For further Information:

Catheryn O'Rourke

Company Secretary

Tel +44 (0) 1753 217 800

 

 

Richard Joyce

Head of Investor Relations

Tel +44 (0) 7408 812 062

 

Reckitt Benckiser Group plc's LEI code is 5493003JFSMOJG48V108

  

About Reckitt:

 

Reckitt* exists to protect, heal and nurture in the relentless pursuit of a cleaner, healthier world. We believe that access to the highest-quality hygiene, wellness and nourishment is a right, not a privilege.

 

Reckitt is the company behind some of the world's most recognisable and trusted consumer brands in hygiene, health and nutrition, including Air Wick, Calgon, Cillit Bang, Clearasil, Dettol, Durex, Enfamil, Finish, Gaviscon, Harpic, Lysol, Mortein, Mucinex, Nurofen, Nutramigen, Strepsils, Vanish, Veet, Woolite and more.

 

Every day, more than 20 million Reckitt products are bought globally. We always put consumers and people first, seek out new opportunities, strive for excellence in all that we do and build shared success with all our partners. We aim to do the right thing, always.

 

We are a diverse global team of more than 43,000 colleagues. We draw on our collective energy to meet our ambitions of purpose-led brands, a healthier planet and a fairer society. Find out more, or get in touch with us at www.reckitt.com

 

*Reckitt is the trading name of the Reckitt Benckiser group of companies

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGPGBUPUPPUBW
Date   Source Headline
15th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20267:00 amRNSTransaction in Own Shares
13th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 20269:42 amRNSTransaction in Own Shares
10th Apr 20267:00 amRNSTransaction in Own Shares
9th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20262:00 pmRNSTotal Voting Rights
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20264:17 pmRNSDirector/PDMR Shareholding
25th Mar 202612:45 pmRNSAnnual Financial Report and Notice of AGM
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 202610:03 amRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 202610:00 amRNSDirector/PDMR Shareholding
13th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20261:00 pmRNSDirector/PDMR Shareholding
9th Mar 20267:00 amRNSCommencement of Third Tranche of Share Buyback
5th Mar 20267:01 amRNSDirectorate change
5th Mar 20267:00 amRNSRESULTS FOR THE YEAR ENDED 31 DECEMBER 2025
2nd Mar 20262:33 pmRNSTotal Voting Rights
23rd Feb 20264:25 pmRNSDirector/PDMR Shareholding
19th Feb 20267:00 amRNSConsumer Analyst Group of New York Conference 2026
2nd Feb 20267:00 amRNSCOMPLETION OF 2ND TRANCHE OF SHARE BUYBACK
2nd Feb 20267:00 amRNSSHARE CONSOLIDATION EFFECTIVE & TOTAL VOTING RIGHT
29th Jan 20267:00 amRNSTransaction in Own Shares
28th Jan 20267:00 amRNSTransaction in Own Shares
27th Jan 20269:00 amRNSResult of General Meeting
27th Jan 20267:00 amRNSTransaction in Own Shares
26th Jan 202610:41 amRNSResponse to Inaccurate Media Article
26th Jan 20267:00 amRNSTransaction in Own Shares
23rd Jan 20267:00 amRNSTransaction in Own Shares
22nd Jan 20267:00 amRNSTransaction in Own Shares
21st Jan 20267:00 amRNSTransaction in Own Shares
20th Jan 20267:00 amRNSTransaction in Own Shares
19th Jan 20267:00 amRNSTransaction in Own Shares
16th Jan 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.